Assertio Holdings, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL, 60045
Mailing Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL, 60045
Phone
(224) 419-7106
Fiscal Year End
1231
EIN
850598378
Financial Overview
FY2025
$173.02M
Total Liabilities
$138.00M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 16, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 20, 2026 | View on SEC |
Annual Reports
10-K
March 16, 2026
- Assertio strategically streamlined its product portfolio by decommercializing Otrexup, aiming for improved long-term profitability and resource allocation.
- Core products like ROLVEDON and Sympazan demonstrated consistent sales, providing a stable revenue base despite overall declines.
Material Events
8-K
Other
January 12, 2026
High Impact
- Assertio Holdings, Inc. has officially regained compliance with Nasdaq's minimum stock price rule.
- The significant risk of delisting from the Nasdaq exchange has been removed.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.